BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 25979950)

  • 1. Warfarin-induced venous limb ischemia/gangrene complicating cancer: a novel and clinically distinct syndrome.
    Warkentin TE; Cook RJ; Sarode R; Sloane DA; Crowther MA
    Blood; 2015 Jul; 126(4):486-93. PubMed ID: 25979950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A career in solving clinical-pathological conundrums: Heyde syndrome, anti-platelet factor 4 disorders, and microvascular limb ischemic necrosis.
    Warkentin TE
    Int J Lab Hematol; 2024 May; 46 Suppl 1():12-26. PubMed ID: 38432651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limb Ischemic Necrosis Secondary to Microvascular Thrombosis: A Brief Historical Review.
    Warkentin TE
    Semin Thromb Hemost; 2024 Jul; 50(5):760-772. PubMed ID: 38688305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergency department ultrasound diagnosis of spontaneous iliopsoas haemorrhage in a patient on warfarin.
    Sharma D; Saker R; Govind A
    BMJ Case Rep; 2013 Nov; 2013():. PubMed ID: 24243507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Warfarin-induced skin necrosis diagnosed on clinical grounds and treated with maggot debridement therapy.
    Biscoe AL; Bedlow A
    BMJ Case Rep; 2013 Jan; 2013():. PubMed ID: 23362073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship Between Symmetrical Peripheral Gangrene Patients and Using Vasopressors in the Intensive Care Unit.
    Alhumam T; Alhumam AA; Alhumaidi I; Al Rajeh I; Alduhailan Y
    Cureus; 2024 Apr; 16(4):e58117. PubMed ID: 38741803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Crosstalk between Nephropathy and Coagulation Disorder: Pathogenesis, Treatment, and Dilemmas.
    Qiu Z; Pang X; Xiang Q; Cui Y
    J Am Soc Nephrol; 2023 Nov; 34(11):1793-1811. PubMed ID: 37487015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous gas gangrene of the lower limb in a patient with rectal cancer: A fatal diagnostic pitfall.
    Mahjoubi MF; Rezgui B; Mabrouk A; Essid N; Jedidi L; Ben Moussa M
    Clin Case Rep; 2022 Sep; 10(9):e6311. PubMed ID: 36177081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinguishing between anti-platelet factor 4/heparin antibodies that can and cannot cause heparin-induced thrombocytopenia.
    Nazi I; Arnold DM; Warkentin TE; Smith JW; Staibano P; Kelton JG
    J Thromb Haemost; 2015 Oct; 13(10):1900-7. PubMed ID: 26291604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of renal failure with the non-vitamin K antagonist oral anticoagulants: systematic review and meta-analysis.
    Caldeira D; Gonçalves N; Pinto FJ; Costa J; Ferreira JJ
    Pharmacoepidemiol Drug Saf; 2015 Jul; 24(7):757-64. PubMed ID: 26009864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dabigatran: Experience in standard clinical practice.
    Álvarez-Otero J; de la Fuente-Aguado J; Arias-Castaño JC; González-González L; Puerta-Louro R; Araújo-Fernández S
    Rev Clin Esp (Barc); 2015 Oct; 215(7):385-90. PubMed ID: 26096376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Effectiveness of Novel Oral Anticoagulants for Stroke Prevention in Non-Valvular Atrial Fibrillation.
    Singh SM; Wijeysundera HC
    Curr Cardiol Rep; 2015 Aug; 17(8):61. PubMed ID: 26081245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-vitamin K antagonist oral anticoagulants: new choices for patient management in atrial fibrillation.
    Saliba W
    Am J Cardiovasc Drugs; 2015 Oct; 15(5):323-35. PubMed ID: 26055615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of gastrointestinal bleeding among patients with atrial fibrillation after initiating dabigatran therapy.
    Lauffenburger JC; Rhoney DH; Farley JF; Gehi AK; Fang G
    Pharmacotherapy; 2015 Jun; 35(6):560-8. PubMed ID: 26044889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is one month treatment with dabigatran before cardioversion of atrial fibrillation sufficient to prevent thromboembolism?
    Johansson AK; Juhlin T; Engdahl J; Lind S; Hagwall K; Rorsman C; Fodor E; Alenholt A; Paul Nordin A; Rosenqvist M; Frick M
    Europace; 2015 Oct; 17(10):1514-7. PubMed ID: 26017466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open-label, phase 1 study to evaluate the effects of hepatic impairment on edoxaban pharmacokinetics and pharmacodynamics.
    Mendell J; Johnson L; Chen S
    J Clin Pharmacol; 2015 Dec; 55(12):1395-405. PubMed ID: 26011596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological management strategies for stroke prevention following transcatheter aortic valve replacement: A systematic review.
    Sterling LH; Windle SB; Filion KB; Eisenberg MJ
    Int J Cardiol; 2015 Jul; 191():303-11. PubMed ID: 26001285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia.
    Warkentin TE; Elavathil LJ; Hayward CP; Johnston MA; Russett JI; Kelton JG
    Ann Intern Med; 1997 Nov; 127(9):804-12. PubMed ID: 9382401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Case Report of Streptococcus Dysgalactiae Toxic Shock Syndrome Complicated with Symmetric Peripheral Gangrene.
    Shen X; Liang H; Wu G; Chen M; Li J
    Infect Drug Resist; 2023; 16():5977-5983. PubMed ID: 37705513
    [No Abstract]   [Full Text] [Related]  

  • 20. Examining the differential of digital ischaemia and review of paraneoplastic ischaemia.
    Zeineddine L; Gomez-Manjarres D
    BMJ Case Rep; 2023 Apr; 16(4):. PubMed ID: 37055076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.